In addition, a study investigating the expression of PD-L1 on circulating epithelial tumor cells (CETCs) of different types of cancer, including prostate cancer, showed that PD-L1 is expressed in 100% of CETCs from prostate cancer patients [16]. This evidence concerns the gene CD274 and prostate cancer.